Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Stock Information | RedChip

Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Listen to this Section


$2.05
+0.1440 ( +7.58% ) 63.9K

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Market Data


Open


$2.05

Previous close


$1.90

Volume


63.9K

Market cap


$33.14M

Day range


$1.82 - $2.06

52 week range


$1.17 - $8.82

Insider Ownership Transactions

Total Amount Purchased: -764,737.00 | $ -1,563,887.17

Date Type Amount Purchased Purchaser
2024-06-18 Sale -12000.00 Scodari Joseph C
2024-06-18 Sale -12000.00 Sailer Carl
2024-06-18 Sale -12000.00 HARRISON THOMAS L
2024-06-18 Sale -12000.00 Donohue James J.
2024-06-18 Sale -12000.00 DEAN JACK H
2024-04-03 Sale -250000.00 LUCI DAVID P
2024-04-03 Sale -145000.00 Shawah Robert G.
2024-04-03 Sale -250000.00 DELUCCIA ROBERT J
2024-01-22 Sale -19737.00 Sailer Carl
2024-01-04 Sale -40000.00 DELUCCIA ROBERT J

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Aug 09, 2024
10-q Quarterly Reports 54 Aug 08, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
8-k 8K-related 13 Jun 17, 2024
8-k 8K-related 14 May 15, 2024
10-q Quarterly Reports 52 May 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.